Skip to main content
Top
Published in: BMC Nephrology 1/2013

Open Access 01-12-2013 | Research article

Do higher dialysate calcium concentrations increase vascular stiffness in haemodialysis patients as measured by aortic pulse wave velocity?

Authors: Evangelia Charitaki, Andrew Davenport

Published in: BMC Nephrology | Issue 1/2013

Login to get access

Abstract

Background

Haemodialysis patients have an increased prevalence of hypertension and risk of cardiovascular mortality and stroke. Higher dialysate calcium concentrations have been reported to cause both an acute and chronic increase in arterial stiffness. We therefore looked at changes in arterial stiffness in established haemodialysis patients to determine whether there was a threshold effect of dialysate calcium concentration linked to change in arterial stiffness.

Methods

We performed pulse wave velocity measurements six months apart in patients dialysing with calcium concentrations of 1.0, 1.25, 1.35 and ≥1.5 mmol/l.

Results

289 patients, 62.2% male, mean age 65.5 ± 15.7 years, weight body mass index 25.8 ± 5.4 kg/m2 ,47.9% diabetic were studied. Systolic blood pressure (SBP) was 148.4 ± 28.6 mmHg and diastolic blood pressure (DBP) 80.2 ± 15.5 mmHg. Mean pulse wave velocity increased over time (9.66 ± 2.0 vs 10.13 ± 2.16 m/s; p < 0.001), but there was no change in aortic augmentation index (38.7 ± 16.3 vs 39.8 ± 15.6%) or central aortic pressure (149.6 ± 33.3 vs 150.4 ± 31.9 mmHg).
Pulse wave velocity did not differ between the four groups either at start or end of the study, but increased both in the groups dialysing with a calcium concentration of 1.0 mmol/l (9.64 ± 1.94 vs 10.45 ± 1.98 m/s, p = 0.0028) and also with 1.35 mmol/l (9.75 ± 1.96 vs 10.21 ± 2.18 m/s, p = 0.02).

Conclusions

Pulse wave velocity increased over the six months study. As pulse wave velocity increased in the group dialysing using the lowest dialysate calcium, it is likely that factors, other than simple net calcium influx and efflux during dialysis according to dialysate calcium concentration are involved with vascular stiffening.
Appendix
Available only for authorised users
Literature
1.
go back to reference Green D, Roberts PR, New DI, Kalra PA: Sudden cardiac death in haemodialysis patients: an in-depth review. Am J Kidney Dis. 2011, 57 (6): 921-929. 10.1053/j.ajkd.2011.02.376.CrossRefPubMed Green D, Roberts PR, New DI, Kalra PA: Sudden cardiac death in haemodialysis patients: an in-depth review. Am J Kidney Dis. 2011, 57 (6): 921-929. 10.1053/j.ajkd.2011.02.376.CrossRefPubMed
2.
go back to reference Noordzij M, Cranenburg EM, Engelsman LF, Hermans MM, Boeschoten EW, Brandenburg VM, Bos WJ, Kooman JP, Dekker FW, Ketteler M, Schurgers LJ, Krediet RT, Korevaar JC, NECOSAD Study Group: Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients. Nephrol Dial Transplant. 2011, 26 (5): 1662-1669. 10.1093/ndt/gfq582.CrossRefPubMed Noordzij M, Cranenburg EM, Engelsman LF, Hermans MM, Boeschoten EW, Brandenburg VM, Bos WJ, Kooman JP, Dekker FW, Ketteler M, Schurgers LJ, Krediet RT, Korevaar JC, NECOSAD Study Group: Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients. Nephrol Dial Transplant. 2011, 26 (5): 1662-1669. 10.1093/ndt/gfq582.CrossRefPubMed
3.
go back to reference Safar ME, Blacher J, Pannier B, Guérin AP, Marchais SJ, Guyonvarc’h PM, London GM: Central pulse pressure and mortality in end stage renal disease. Hypertension. 2002, 39: 735-738. 10.1161/hy0202.098325.CrossRefPubMed Safar ME, Blacher J, Pannier B, Guérin AP, Marchais SJ, Guyonvarc’h PM, London GM: Central pulse pressure and mortality in end stage renal disease. Hypertension. 2002, 39: 735-738. 10.1161/hy0202.098325.CrossRefPubMed
4.
go back to reference LeBeouf A, Mac-Way F, Utescu MS, Chbinou N, Douville P, Desmeules S, Agharazii M: Effects of acute variation of dialysate calcium concentrations on arterial stiffness and aortic pressure waveform. Nephrol Dial Transplant. 2009, 24 (12): 3788-3794. 10.1093/ndt/gfp351.CrossRefPubMedPubMedCentral LeBeouf A, Mac-Way F, Utescu MS, Chbinou N, Douville P, Desmeules S, Agharazii M: Effects of acute variation of dialysate calcium concentrations on arterial stiffness and aortic pressure waveform. Nephrol Dial Transplant. 2009, 24 (12): 3788-3794. 10.1093/ndt/gfp351.CrossRefPubMedPubMedCentral
5.
go back to reference Kyriazis J, Katsipi I, Stylianou K, Jenakis N, Karida A, Daphnis E: Arterial stiffness alterations during haemodialysis: the role of dialysate calcium. Nephron Clin Pract. 2007, 106 (1): c34-42. 10.1159/000101482.CrossRefPubMed Kyriazis J, Katsipi I, Stylianou K, Jenakis N, Karida A, Daphnis E: Arterial stiffness alterations during haemodialysis: the role of dialysate calcium. Nephron Clin Pract. 2007, 106 (1): c34-42. 10.1159/000101482.CrossRefPubMed
6.
go back to reference Davenport A, Gardner C, Delaney M, Pan Thames Renal Audit Group: Do differences in dialysis prescription impact on KDOQI bone mineral targets? The Pan Thames Renal Audit. Blood Purif. 2010, 30 (2): 111-117. 10.1159/000319954.CrossRefPubMed Davenport A, Gardner C, Delaney M, Pan Thames Renal Audit Group: Do differences in dialysis prescription impact on KDOQI bone mineral targets? The Pan Thames Renal Audit. Blood Purif. 2010, 30 (2): 111-117. 10.1159/000319954.CrossRefPubMed
7.
go back to reference Marchais S, Guérin A, Safar M, London G: Arterial compliance in uraemia. J Hypertens Suppl. 1989, 7 (6): S84-85.CrossRefPubMed Marchais S, Guérin A, Safar M, London G: Arterial compliance in uraemia. J Hypertens Suppl. 1989, 7 (6): S84-85.CrossRefPubMed
8.
go back to reference LeBoeuf A, Mac-Way F, Utescu MS, De Serres SA, Douville P, Desmeules S, Lebel M, Agharazii M: Impact of dialysate calcium concentration on the progression of aortic stiffness in patients on haemodialysis. Nephrol Dial Transplant. 2011, 26 (11): 3695-3701. 10.1093/ndt/gfr138.CrossRefPubMed LeBoeuf A, Mac-Way F, Utescu MS, De Serres SA, Douville P, Desmeules S, Lebel M, Agharazii M: Impact of dialysate calcium concentration on the progression of aortic stiffness in patients on haemodialysis. Nephrol Dial Transplant. 2011, 26 (11): 3695-3701. 10.1093/ndt/gfr138.CrossRefPubMed
9.
go back to reference Kim JK, Moon SJ, Park HC, Lee JS, Sim SR, Bae SC, Ha SK: Effects of lowering dialysate calcium concentrations on arterial stiffness in patients undergoing haemodialysis. Korean J Intern Med. 2011, 26 (3): 320-327. 10.3904/kjim.2011.26.3.320.CrossRefPubMedPubMedCentral Kim JK, Moon SJ, Park HC, Lee JS, Sim SR, Bae SC, Ha SK: Effects of lowering dialysate calcium concentrations on arterial stiffness in patients undergoing haemodialysis. Korean J Intern Med. 2011, 26 (3): 320-327. 10.3904/kjim.2011.26.3.320.CrossRefPubMedPubMedCentral
10.
go back to reference Demirci MS, Ozkahya M, Asci G, Sevinc E, Yilmaz M, Demirci C, Toz H, Basci A, Ok E: The influence of dialysate calcium on progression of arterial stiffness in peritoneal dialysis patients. Perit Dial Int. 2009, 29 (Suppl 2): S15-17.PubMed Demirci MS, Ozkahya M, Asci G, Sevinc E, Yilmaz M, Demirci C, Toz H, Basci A, Ok E: The influence of dialysate calcium on progression of arterial stiffness in peritoneal dialysis patients. Perit Dial Int. 2009, 29 (Suppl 2): S15-17.PubMed
11.
go back to reference Messa P: The ups and downs of dialysate calcium concentration in haemodialysis patients. Nephrol Dial Transplant. 2013, 28 (1): 3-7. 10.1093/ndt/gfs363.CrossRefPubMed Messa P: The ups and downs of dialysate calcium concentration in haemodialysis patients. Nephrol Dial Transplant. 2013, 28 (1): 3-7. 10.1093/ndt/gfs363.CrossRefPubMed
12.
go back to reference Horváth IG, Németh A, Lenkey Z, Alessandri N, Tufano F, Kis P, Gaszner B, Cziráki A: Invasive validation of a new oscillometric device (Arteriograph) for measuring augmentation index, central blood pressure and aortic pulse wave velocity. J Hypertens. 2010, 28 (10): 2068-2075. 10.1097/HJH.0b013e32833c8a1a.CrossRefPubMed Horváth IG, Németh A, Lenkey Z, Alessandri N, Tufano F, Kis P, Gaszner B, Cziráki A: Invasive validation of a new oscillometric device (Arteriograph) for measuring augmentation index, central blood pressure and aortic pulse wave velocity. J Hypertens. 2010, 28 (10): 2068-2075. 10.1097/HJH.0b013e32833c8a1a.CrossRefPubMed
13.
go back to reference Vernon K, Peasegood J, Riddell A, Davenport A: Dialyzers designed to increase internal filtration do not result in significantly increased platelet activation and thrombin generation. Nephron Clin Pract. 2010, 117 (4): c403-c408.CrossRefPubMed Vernon K, Peasegood J, Riddell A, Davenport A: Dialyzers designed to increase internal filtration do not result in significantly increased platelet activation and thrombin generation. Nephron Clin Pract. 2010, 117 (4): c403-c408.CrossRefPubMed
14.
go back to reference Davenport A: Low-molecular-weight heparin as an alternative anticoagulant to unfractionated heparin for routine outpatient haemodialysis treatments. Nephrology (Carlton). 2009, 14: 455-461. 10.1111/j.1440-1797.2009.01135.x.CrossRef Davenport A: Low-molecular-weight heparin as an alternative anticoagulant to unfractionated heparin for routine outpatient haemodialysis treatments. Nephrology (Carlton). 2009, 14: 455-461. 10.1111/j.1440-1797.2009.01135.x.CrossRef
15.
go back to reference Seliger SL, Gillen DL, Tirschwell D, Wasse H, Kestenbaum BR, Stehman-Breen CO: Risk factors for incident stroke among patients with end-stage renal disease. J Am Soc Nephrol. 2003, 14 (10): 2623-2631. 10.1097/01.ASN.0000088722.56342.A8.CrossRefPubMed Seliger SL, Gillen DL, Tirschwell D, Wasse H, Kestenbaum BR, Stehman-Breen CO: Risk factors for incident stroke among patients with end-stage renal disease. J Am Soc Nephrol. 2003, 14 (10): 2623-2631. 10.1097/01.ASN.0000088722.56342.A8.CrossRefPubMed
16.
go back to reference Davenport A: Intradialytic complications during haemodialysis. Haemodial Int. 2006, 10: 162-167. 10.1111/j.1542-4758.2006.00088.x.CrossRef Davenport A: Intradialytic complications during haemodialysis. Haemodial Int. 2006, 10: 162-167. 10.1111/j.1542-4758.2006.00088.x.CrossRef
17.
go back to reference McIntyre CW, Burton JO, Selby NM, Leccisotti L, Korsheed S, Baker CS, Camici PG: Haemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol. 2008, 3: 19-26. 10.2215/CJN.03170707.CrossRefPubMedPubMedCentral McIntyre CW, Burton JO, Selby NM, Leccisotti L, Korsheed S, Baker CS, Camici PG: Haemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol. 2008, 3: 19-26. 10.2215/CJN.03170707.CrossRefPubMedPubMedCentral
18.
go back to reference Davenport A, Buscombe JR: Watershed cerebral infarction in a haemodialysis patient. Kidney Int. 2010, 77 (12): 1140-10.1038/ki.2010.61.CrossRefPubMed Davenport A, Buscombe JR: Watershed cerebral infarction in a haemodialysis patient. Kidney Int. 2010, 77 (12): 1140-10.1038/ki.2010.61.CrossRefPubMed
19.
go back to reference Gotch FA, Kotanko P, Thijssen S, Levin NW: The KDIGO guideline for dialysate calcium will result in an increased incidence of calcium accumulation in haemodialysis patients. Kidney Int. 2010, 78 (4): 343-350. 10.1038/ki.2010.157.CrossRefPubMed Gotch FA, Kotanko P, Thijssen S, Levin NW: The KDIGO guideline for dialysate calcium will result in an increased incidence of calcium accumulation in haemodialysis patients. Kidney Int. 2010, 78 (4): 343-350. 10.1038/ki.2010.157.CrossRefPubMed
20.
go back to reference Shroff RC, Shanahan CM: The vascular biology of calcification. Semin Dial. 2007, 20 (2): 103-109. 10.1111/j.1525-139X.2007.00255.x.CrossRefPubMed Shroff RC, Shanahan CM: The vascular biology of calcification. Semin Dial. 2007, 20 (2): 103-109. 10.1111/j.1525-139X.2007.00255.x.CrossRefPubMed
21.
go back to reference Gabutti L, Bianchi G, Soldini D, Marone C, Burnier M: Haemodynamic consequences of changing bicarbonate and calcium concentrations in haemodialysis fluids. Nephrol Dial Transplant. 2009, 24 (3): 973-981.CrossRefPubMed Gabutti L, Bianchi G, Soldini D, Marone C, Burnier M: Haemodynamic consequences of changing bicarbonate and calcium concentrations in haemodialysis fluids. Nephrol Dial Transplant. 2009, 24 (3): 973-981.CrossRefPubMed
22.
go back to reference Jean G, Mayor B, Hurot JM, Deleaval P, Lorriaux C, Zaoui E, Chazot C: Biological impact of targeted dialysate calcium changes in haemodialysis patients: the key role of parathyroid hormone. Nephrol Dial Transplant. 2013, 28 (1): 176-182. 10.1093/ndt/gfs119.CrossRefPubMed Jean G, Mayor B, Hurot JM, Deleaval P, Lorriaux C, Zaoui E, Chazot C: Biological impact of targeted dialysate calcium changes in haemodialysis patients: the key role of parathyroid hormone. Nephrol Dial Transplant. 2013, 28 (1): 176-182. 10.1093/ndt/gfs119.CrossRefPubMed
23.
go back to reference Morey B, Walker R, Davenport A: More dietetic time, better outcome? A randomized prospective study investigating the effect of more dietetic time on phosphate control in end stage kidney failure haemodialysis patients. Nephron Clin Pract. 2008, 109: c173-c180. 10.1159/000145462.CrossRefPubMed Morey B, Walker R, Davenport A: More dietetic time, better outcome? A randomized prospective study investigating the effect of more dietetic time on phosphate control in end stage kidney failure haemodialysis patients. Nephron Clin Pract. 2008, 109: c173-c180. 10.1159/000145462.CrossRefPubMed
Metadata
Title
Do higher dialysate calcium concentrations increase vascular stiffness in haemodialysis patients as measured by aortic pulse wave velocity?
Authors
Evangelia Charitaki
Andrew Davenport
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2013
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-14-189

Other articles of this Issue 1/2013

BMC Nephrology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.